NPM1 p.W288Cfs*12
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (1) | NPM1 p.W288Cfs*12 | Acute Myeloid Leukemia | Ziftomenib | |
| FDA (1) | NPM1 p.W288Cfs*12 | Acute Myeloid Leukemia | Revumenib | |
| FDA (1) | NPM1 p.W288Cfs*12 | Acute Lymphoid Leukemia | Revumenib | |
| FDA (1) | NPM1 p.W288Cfs*12 | Burkitt Lymphoma | Revumenib | |
| FDA (1) | NPM1 p.W288Cfs*12 | Acute Leukemias of Ambiguous Lineage | Revumenib |